DODD DAVID A
Known title: President, CEOCIK: 0001193607
DODD DAVID A's purchase track record
How the stock did after each of DODD DAVID A's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
5
of 5 since April 24, 2023
Stock higher 6 months later
20%
3 months: 20%
Median 6-month return
-20.6%
3 months: -13.0%
Beat the S&P 500
20%
median -22.5% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 4/1/2025 | GOVX | $11K | -55.1% | -56.2% | +18.7% |
| 8/9/2024 | GOVX | $16K | +4.6% | -8.8% | +12.8% |
| 2/21/2024 | GOVX | $20K | -15.0% | +279.6% | +12.8% |
| 8/25/2023 | GOVX | $20K | -13.0% | -74.1% | +15.5% |
| 4/24/2023 | GOVX | $20K | -10.2% | -20.6% | +1.9% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| GOVX | ▲ Buy | Open Market | 10,000 | $11K | 4/1/2025 | View on chart |
| GOVX | ▲ Buy | Open Market | 8,000 | $16K | 8/9/2024 | View on chart |
| GOVX | ▲ Buy | Open Market | 8,209 | $19K | 2/22/2024 | View on chart |
| GOVX | ▲ Buy | Open Market | 520 | $1K | 2/21/2024 | View on chart |
| GOVX | ▲ Buy | Open Market | 35,087 | $20K | 8/25/2023 | View on chart |
| GOVX | ▲ Buy | Open Market | 32,000 | $20K | 4/24/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 3, 2026
GeoVax Notes Sustained Clade Ib Mpox Transmission in US
GeoVax Labs reported that Clade Ib mpox transmission in the United States is likely to be sustained. This development is relevant as the company focuses on mpox-related solutions. The stock currently trades near its 52-week low, reflecting broader market conditions.
GeoVax Notes Sustained Clade Ib Mpox Transmission in US. GeoVax Labs reported that Clade Ib mpox transmission in the United States is likely to be sustained. This development is relevant as the company focuses on mpox-related solutions. The stock currently trades near its 52-week low, reflecting broader market conditions.